Wednesday - October 14, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Jiangmen Shuizirun Sanitary Articles
October 14, 2026
WASHINGTON, Oct. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Jiangmen Shuizirun Sanitary Articles Co. Ltd. from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Huashen Liang, General Manager, Jiangmen Shuizirun Sanitary Articles Co., Ltd., Boyukou, Liangdechong Highway, Sanjiangzhen, Xinhui Qu Jiangmen Shi Guangdong Sheng, 529142, China

Issuing Office: Center fo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products